ArticleCells2024

A Novel CRISPR-Cas9 Strategy to Target DYSTROPHIN Mutations Downstream of Exon 44 in Patient-Specific DMD iPSCs.

Neha R Dhoke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.